Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Vistin Pharma ASA's operating assets for the quarter that ended in Mar. 2026 was €40.05 Mil. Vistin Pharma ASA's operating liabilities for the quarter that ended in Mar. 2026 was €9.25 Mil. Vistin Pharma ASA's Total Assets for the quarter that ended in Dec. 2025 was €37.13 Mil. Therefore, Vistin Pharma ASA's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.83.
Vistin Pharma ASA Scaled Net Operating Assets Related Terms
Vistin Pharma ASA Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Vistin Pharma ASA's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vistin Pharma ASA Scaled Net Operating Assets Chart
FRA:VP4 vs ZTS, UTHR, VTRS: Scaled Net Operating Assets Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vistin Pharma ASA Scaled Net Operating Assets vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Vistin Pharma ASA's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.83 mean?
Vistin Pharma ASA (FRA:VP4) has a Scaled Net Operating Assets of 0.83 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Vistin Pharma ASA and its competitors.
Is Vistin Pharma ASA's Scaled Net Operating Assets too high?
Vistin Pharma ASA's current Scaled Net Operating Assets is 0.83. Overall, Vistin Pharma ASA has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vistin Pharma ASA's Scaled Net Operating Assets compare to ZTS and UTHR?
Vistin Pharma ASA's Scaled Net Operating Assets of 0.83 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Vistin Pharma ASA and its competitors. Vistin Pharma ASA's current Scaled Net Operating Assets is 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vistin Pharma ASA stock overvalued right now?
Based on GuruFocus' analysis, Vistin Pharma ASA (FRA:VP4) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.27, compared to a current price of €1.79 — trading 21.1% below its estimated fair value. The current Scaled Net Operating Assets is 0.83. Vistin Pharma ASA's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Vistin Pharma ASA (FRA:VP4), the current Scaled Net Operating Assets is 0.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vistin Pharma ASA (FRA:VP4) Overvalued in 2026?
Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued.
The current stock price of €1.79 is trading 21.1% below its estimated GF Value™ of €2.27.
GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.
Key valuation signals for FRA:VP4:
Scaled Net Operating Assets: 0.83
GF Value™: €2.27 vs. price of €1.79 (21.1% below fair value)
No single metric tells the full story. See the FRA:VP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
80GF Score
Get the complete analysis for FRA:VP4
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VP4 has been successfully added to your 
